Citing Liver Damage, Pfizer Withdraws Thelin

NEW YORK - (AP) Pfizer Inc. said Friday it is pulling its blood pressure drug Thelin off the market and stopping all clinical trials because the drug can cause fatal liver damage. Thelin is sold in the European Union, Canada, and Australia as an oral treatment for severe pulmonary arterial hypertension. . . . Full version available to subscribers.